Selected issues regarding cell therapies in light of reports presented at the 33rd Regional Congress of the International Society of Blood Transfusion (ISBT) in Gothenburg, June 17–21, 2023

The International Society of Blood Transfusion (ISBT) is a leading society combining a global community of professionals who share the knowledge on clinical and laboratory transfusion, as well as the safety of blood and blood components for the welfare of blood donors and patients. Every two years ISBT organizes international and regional congresses. On June 17–21, the 33rd Regional Congress was hosted by Göteborg (Sweden). This congress was organized jointly with the Swedish Society for Clinical Immunology and Transfusion Medicine (KITM, Svensk Förening för Klinisk Immunologi och Transfusionsmedicin). The congress agenda included: Nordic Day (June 17), during which reports from five Scandinavian countries were presented, Academy Day (June 18), during which educational lectures covering practical aspects of the most recent topics in transfusion medicine were presented, three days (June 19–21) of sessions presenting the latest reports in the field of transfusion medicine and the related fields. This paper presents some selected issues related to cell therapies presented during the Congress.